


Healthcare | Small Cap
Accent Microcell Ltd demonstrates robust financial health, characterized by exceptional growth and outstanding profitability. The company is expanding at a very rapid pace across sales, profits, and its asset base, indicating strong market demand and successful strategic execution. Its profitability is a key strength, with high margins and excellent returns on investment. Furthermore, the company operates with virtually no debt, giving it a superior level of long-term financial stability and very low risk. However, this rapid growth presents challenges in operational efficiency. A notable weakness is the significant amount of time it takes to collect payments from customers, which could strain cash flow. Additionally, the overall effectiveness of using its large capital base to generate sales is low. The company is heavily reinvesting its earnings into expansion, as shown by high capital spending and low dividend payouts. The future outlook is positive, driven by strong growth momentum, but hinges on managing operational efficiencies as it scales.
Accent Microcell Ltd demonstrates robust financial health, characterized by exceptional growth and outstanding profitability. The company is expanding at a very rapid pace across sales, profits, and its asset base, indicating strong market demand and successful strategic execution. Its profitability is a key strength, with high margins and excellent returns on investment. Furthermore, the company operates with virtually no debt, giving it a superior level of long-term financial stability and very low risk. However, this rapid growth presents challenges in operational efficiency. A notable weakness is the significant amount of time it takes to collect payments from customers, which could strain cash flow. Additionally, the overall effectiveness of using its large capital base to generate sales is low. The company is heavily reinvesting its earnings into expansion, as shown by high capital spending and low dividend payouts. The future outlook is positive, driven by strong growth momentum, but hinges on managing operational efficiencies as it scales.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
23.12
Industry Median
36.13
Small Cap Median
35.79
P/E RATIO
24.25
P/B RATIO
3.21
Industry Median
6.08
Small Cap Median
6.08
P/S RATIO
3.03
Industry Median
5.75
Small Cap Median
5.17
Others
PEG RATIO
0.47
EV/EBITDA RATIO
16.71
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹334.1 as on May 29, 2026.
The company is in a phase of exceptional and widespread growth. It is expanding at an extremely high rate across all major indicators, including revenue, operating profit, and earnings per share. This powerful growth trajectory is supported by a rapid expansion of its asset base, indicating strong market acceptance and successful execution of its expansion strategy. This is a primary strength of the company.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 24.81 | 18.67 | 24.87 | 7.72 | 31.7 |
| Operating Profit Growth Rate | 18.18 | 46.15 | 105.26 | 7.69 | 35.71 |
| Earnings Per Share (EPS) Growth | -59.08 | 105.99 | 52.18 | 9.63 | 32.66 |
| Asset Growth Rate | 17.28 | 16.84 | 84.68 | 11.22 | 41.23 |
| Net Income Growth Rate | 20 | 100 | 150 | 10 | 33.33 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Accent Microcell Ltd | 7.96 | 24.25 | Neutral | 57.00 | 18.28 | 44.00 |
| 2 | Lincoln Pharmaceuticals Ltd | 7.31 | 13.81 | Neutral | 98.00 | 43.88 | 88.00 |
| 3 | Kilitch Drugs (India) Ltd | 7.12 | 22.83 | Neutral | 37.00 | 9.27 | 30.00 |
| 4 | NGL Fine Chem Ltd | 6.98 | 44.01 | Overvalued | 73.00 | 67.39 | 48.00 |
| 5 | Sakar Healthcare Ltd | 6.89 | 67.13 | Highly Overvalued | 69.00 | 13.70 | 30.00 |
| 6 | Medico Remedies Ltd | 6.61 | 37.70 | Overvalued | 17.00 | 1.58 | 13.00 |
| 7 | Kopran Ltd | 6.60 | 25.82 | Neutral | 62.00 | 6.30 | 26.00 |
| 8 | SMS Lifesciences India Ltd | 6.59 | 21.63 | Undervalued | 45.00 | 58.80 | 19.00 |
| 9 | Infinium Pharmachem Ltd | 6.42 | 26.92 | Neutral | 22.00 | 6.43 | 14.00 |
| 10 | Medicamen Biotech Ltd | 5.73 | 33.43 | Neutral | 20.00 | 6.94 | 10.00 |
| 11 | Albert David Ltd | 5.63 | -279.90 | Neutral | 5.00 | -2.62 | -1.00 |
| 12 | BPL Ltd | 5.46 | -30.53 | Neutral | -4.82 | -1.69 | -8.55 |
| 13 | Zim Laboratories Ltd | 5.41 | 41.96 | Neutral | 30.00 | 1.11 | 6.00 |
| 14 | Remus Pharmaceuticals Ltd | 5.31 | 25.82 | Neutral | 57.00 | 20.97 | 46.00 |
| 15 | Ind-Swift Laboratories Ltd | 4.95 | 47.48 | Neutral | 45.00 | 4.89 | 41.00 |
| 16 | Venus Remedies Ltd | 4.83 | 23.37 | Neutral | 147.00 | 74.30 | 103.00 |
| 17 | Wanbury Ltd | 4.65 | 29.43 | Neutral | 88.00 | 18.93 | 43.00 |
| 18 | Nectar Lifescience Ltd | 3.83 | -2.67 | Neutral | -59.00 | -2.95 | -293.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral